Transposagen Biophamaceuticals Overview
- Founded
- 2003
- Status
- Private
- Employees
- 20
- Latest Deal Type
- Grant
- Latest Deal Amount
- $4.3M
- Investors
- 1
Transposagen Biophamaceuticals General Information
Description
Developer of animal models, cell lines, stem cells, research tools and technologies to improve drug discovery and development research. The company is biotechnology based and provides genetically modified rat models to pharmaceutical and biotechnology companies, academic laboratories and the National Institutes of Health.
Contact Information
Website
www.transposagenbio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
- 535 West Second Street
- Suite L102
- Lexington, KY 40508
- United States
+1 (859) 000-0000
Transposagen Biophamaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 21-Jun-2013 | $4.3M | 00.000 | Completed | Generating Revenue | |
| 3. Angel (individual) | 18-Jul-2012 | 00000 | 00.000 | Completed | Generating Revenue | |
| 2. Angel (individual) | 20-Dec-2011 | $725K | $725K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Transposagen Biophamaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of animal models, cell lines, stem cells, research tools and technologies to improve drug discovery and develo
Biotechnology
Lexington, KY
20
As of 2015
00.000
0000000000
00.000
0000000
is aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
00000 000000000000000 000 0000000000000
Cambridge, United Kingdom
000
As of 0000
00000
0000
0000-00-00
000000&0
00000
0000000
fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
0000000000000
Berkeley, CA
00
As of 0000
00000
0000
0000-00-00
00000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialTransposagen Biophamaceuticals Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Horizon Discovery | Formerly VC-backed | Cambridge, United Kingdom | 000 | 00000 | 000000&0 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | Berkeley, CA | 00 | 00000 | 00000000000 | 00000 |
| 0000000 | Corporation | Seoul, South Korea | 00 | |||
| 0000000 0000000000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 000000&0 | |
| 000000 00000000000 | Formerly VC-backed | Zug, Switzerland | 000 | 00000 | 00000000000 | 00000 |
Transposagen Biophamaceuticals Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Eric Ostertag Ph.D | Chief Executive Officer & President |
Transposagen Biophamaceuticals Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Nishan Silva MD | Self | Board Member | 000 0000 |
Transposagen Biophamaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTransposagen Biophamaceuticals Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Johns Hopkins Technology Ventures | Accelerator/Incubator | 000 0000 | 000000 0 |